Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors
01 mars 2021 16h05 HE
|
Agile Therapeutics, Inc.
Perceptive Advisors Increases Credit Facility to $45 million, with $25 million potentially available Achieved Gross Revenue Target In Fourth Quarter 2020, Reflecting Initial Stocking of Twirla®...
Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
19 févr. 2021 08h35 HE
|
Agile Therapeutics, Inc.
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will...
Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
08 mars 2017 16h15 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company today reported financial results for the three months...
AGRX NOTICE: Rosen Law Firm Reminds Agile Therapeutics Investors of Important Class Action Deadline – AGRX
15 févr. 2017 14h30 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 15, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Agile Therapeutics, Inc. securities (NASDAQ:AGRX) from March 9, 2016 through...
Lawsuit for Investors in Agile Therapeutics Inc (NASDAQ:AGRX) shares announced by Shareholders Foundation
30 janv. 2017 09h40 HE
|
Shareholders Foundation, Inc.
SAN DIEGO, Jan. 30, 2017 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New Jersey on behalf of certain purchasers of shares of Agile Therapeutics Inc...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. – AGRX
26 janv. 2017 12h16 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Agile Therapeutics, Inc....
Agile Therapeutics to Present at Biotech Showcase 2017
22 déc. 2016 08h00 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) announced today that its Chief Executive Officer, Al Altomari will present at the Biotech Showcase 2017 on...
Agile Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
22 déc. 2016 07h30 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company, announced today that its Chief Executive Officer, Al...
Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters
04 févr. 2016 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
22 janv. 2016 09h16 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...